Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis.
Erratum: microRNA dysregulation in multiple sclerosis.
Neural Crest Cells Isolated from the Bone Marrow of Transgenic Mice Express JCV T-Antigen.
Sodium ((23)Na) ultra-short echo time imaging in the human brain using a 3D-Cones trajectory.
Towards an endophenotype in multiple sclerosis.
Autoantibodies in neuroimmunological diseases; relevance of fine specificity.
Synergistic Interactions between Cytokines and AVP at the Blood-CSF Barrier Result in Increased Chemokine Production and Augmented Influx of Leukocytes after Brain Injury.
Autoimmunity in multiple sclerosis need not be abnormal.
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.
Ophthalmic manifestations of systemic diseases-part 2: metabolic, infections, granulomatoses, demyelination, and skeletal dysplasias.
Quality of life and cognitive functions in early onset multiple sclerosis.
NLRP3 inflammasome and its inhibitors: a review.
Measuring Water Content using T2 Relaxation at 3T: Phantom Validations and Simulations.
Tryptophan Metabolites and Their Impact on Multiple Sclerosis Progression.
Role of myelin sheath energy metabolism in neurodegenerative diseases.
EOP, a Newly Synthesized Ethyl Pyruvate Derivative, Attenuates the Production of Inflammatory Mediators via p38, ERK and NF-κB Pathways in Lipopolysaccharide-Activated BV-2 Microglial Cells.
MS Prevalence and Patients' Characteristics in the District of Braga, Portugal.
[Assessment of the effectiveness and safety of Sativex ® in compassionate use].
Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis.
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy.
Multiple sclerosis (MS) for the urologist: What should urologists know about MS?
Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease.
The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients.
Pages
« first
‹ previous
…
524
525
526
527
528
529
530
531
532
…
next ›
last »